Reminder: Intellia Investors in Pending Class Action Lawsuit, Gross Law Firm Notes
Investors in Intellia Therapeutics, Inc. have been reminded by The Gross Law Firm of an upcoming class action lawsuit with a lead plaintiff deadline of April 14, 2025. The lawsuit is related to allegations that Intellia and certain of its officers and directors may have engaged in securities fraud.
The class action lawsuit focuses on allegations that Intellia may have made materially false and misleading statements to investors. These alleged misrepresentations relate to the safety and efficacy of the company’s lead product candidate, which is aimed at treating a rare genetic disease. It is claimed that Intellia failed to disclose certain information that was necessary for investors to make informed decisions about the potential risks associated with the product candidate.
Investors who purchased shares of Intellia between April 20, 2021, and February 15, 2022, are encouraged to participate in the lawsuit. The lead plaintiff deadline is fast approaching, and investors who wish to be a part of the lawsuit must take action before April 14, 2025.
The Gross Law Firm is a national shareholder rights litigation firm that represents investors and shareholders in various types of securities litigation. The firm’s focus is on ensuring that companies are held accountable for any potential violations of securities laws and that investors are able to seek justice for any losses they may have suffered as a result.
Investors who believe they may have been impacted by the alleged misconduct at Intellia are urged to contact The Gross Law Firm for more information on how to participate in the class action lawsuit. By joining the lawsuit, investors may be able to recover some of their losses if the allegations of securities fraud are proven to be true.
As the lead plaintiff deadline approaches, it is essential for investors to act promptly if they wish to be involved in the class action lawsuit against Intellia. By working with experienced securities litigation attorneys, investors can ensure that their rights are protected and that they have the opportunity to seek justice for any harm they may have suffered due to alleged securities fraud.